ONCLIVE NEWS NETWORK: ON LOCATION WILL BE LIVE AT ESMO THIS WEEK - STAY TUNED FOR MORE INFORMATION!

Dr. Chlebowski on How Weight Loss Improves TNBC Survival

Rowan Chlebowski, MD, PhD
Published: Tuesday, Dec 16, 2014



As few as five pounds of weight loss can make a significant difference for patients with triple-negative breast cancer, says Rowan Chlebowski, MD, PhD, a medical oncologist at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center.

Among patients following a program to reduce their dietary fat intake, those with estrogen receptor (ER)-negative breast cancer had a reduction of death of 36%, while ER- and progesterone receptor (PR)-negative patients had a 54% reduction of death compared to the control group.

Losing even a small amount of weight can impact factors that drive tumor growth like glucose metabolism, inflammatory factors, and diabetes, says Chlebowski.

More research is needed to validate these findings from a scientific standpoint, but because five pounds of weight loss is such a simple change, Chlebowski suggests breast cancer patients put it into practice now.

<<< View more from the 2014 San Antonio Breast Cancer Symposium



As few as five pounds of weight loss can make a significant difference for patients with triple-negative breast cancer, says Rowan Chlebowski, MD, PhD, a medical oncologist at the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center.

Among patients following a program to reduce their dietary fat intake, those with estrogen receptor (ER)-negative breast cancer had a reduction of death of 36%, while ER- and progesterone receptor (PR)-negative patients had a 54% reduction of death compared to the control group.

Losing even a small amount of weight can impact factors that drive tumor growth like glucose metabolism, inflammatory factors, and diabetes, says Chlebowski.

More research is needed to validate these findings from a scientific standpoint, but because five pounds of weight loss is such a simple change, Chlebowski suggests breast cancer patients put it into practice now.

<<< View more from the 2014 San Antonio Breast Cancer Symposium


View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Interchange™: Translating Research to Inform Changing Paradigms: Assessment of Emerging Immuno-Oncology Strategies and Combinations across Lung, Head and Neck, and Bladder CancersOct 31, 20182.0
Community Practice Connections: Oncology Best Practice™ Targeting Cell Cycle Progression: The Latest Advances on CDK4/6 Inhibition in Metastatic Breast CancerOct 31, 20181.0
Publication Bottom Border
Border Publication
x